Alkermes (ALKS) Tops Q4 EPS by 2c; Issues Strong FY13 EPS Outlook
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $48.33 +0.65%
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q4 EPS of ($0.14), $0.02 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $130.5 million versus the consensus estimate of $125.88 million.
Alkermes sees FY2013 EPS of $0.62-$0.77, versus the consensus of $-0.29. Alkermes sees FY2013 revenue of $490-$530 million, versus the consensus of $522.94 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Alkermes sees FY2013 EPS of $0.62-$0.77, versus the consensus of $-0.29. Alkermes sees FY2013 revenue of $490-$530 million, versus the consensus of $522.94 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- CoStar Group acquires Zonda for $800M, adding new home data
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
